523031 — ADS Diagnostic Share Price
Last trade - 00:00Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 46.78% | ||
| Return on Equity | 32.57% | ||
| Operating Margin | 11.02% | ||
Financial Summary
| Year End 31st Mar | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 89.51 | 143.31 | 106.19 | 104.18 | 137.74 | n/a | n/a | 16.63% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +232.5 | -44.5 | -28.6 | +21.53 | +173.81 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
ADS Diagnostic Limited is an India-based medical instrument company. The Company is engaged in the business of trading of diagnostic medical consumables and electronic consumables, and services of medical equipment’s and machines. The Company has 14 numbers Hologic trained service engineers for both dexa and mammography machine. The Company’s products include Hologic BMD Horizon, Hologic BMD Discovery and Selenia Dimensions.
Directors
- Last Annual
- March 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- June 23rd, 1984
- Public Since
- June 23rd, 1984
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Bombay Stock Exchange
- Shares in Issue
- 2,192,800
- Address
- 114 Sant Nagar, East Of Kailash, NEW DELHI, 110065
- Web
- https://adsdiagnosticlimited.com/
- Phone
- +91 1141622193
- Auditors
- V. N. Purohit & Co.
Upcoming Events for 523031
Similar to 523031
Aashka Hospitals
Bombay Stock Exchange
Asarfi Hospital
Bombay Stock Exchange
Aspira Pathlab & Diagnostics
Bombay Stock Exchange
Chennai Meenakshi Multispeciality Hospital
Bombay Stock Exchange
Dhanvantri Jeevan Rekha
Bombay Stock Exchange
FAQ
As of Today at 19:00 UTC, shares in ADS Diagnostic are trading at IN₹11.34. This share price information is delayed by 15 minutes.
Shares in ADS Diagnostic last closed at IN₹11.34 and the price had moved by +5% over the past 365 days. In terms of relative price strength the ADS Diagnostic share price has underperformed the S&P BSE 100 Index by -18.56% over the past year.
There is no consensus recommendation for this security.
ADS Diagnostic does not currently pay a dividend.
ADS Diagnostic does not currently pay a dividend.
ADS Diagnostic does not currently pay a dividend.
To buy shares in ADS Diagnostic you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹11.34, shares in ADS Diagnostic had a market capitalisation of .
Here are the trading details for ADS Diagnostic:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 523031
Based on an overall assessment of its quality, value and momentum ADS Diagnostic is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like ADS Diagnostic. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -10.27%.
As of the last closing price of IN₹11.34, shares in ADS Diagnostic were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The ADS Diagnostic PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹11.34.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on ADS Diagnostic's directors